Ameer Receives Technology Innovation and Development Award

The Society for Biomaterials has awarded Professor Guillermo Ameer its 2022 Technology Innovation and Development Award, which recognizes "an individual’s (or a team’s) successful application of basic and applied biomaterials research in the development of a novel medical product or technology that significantly benefits the health and well-being of medical and surgical patients."  The award highlights Ameer's work describing the synthesis of bioresorbable biomaterials based on citric acid and subsequent development of the Citregen biomaterial technology for implantable medical devices, discoveries that have generated both specific medical devices and new avenues of research for other investigators.  From the award citation,

"His research group at Northwestern University was the first to describe the synthesis of bioresorbable biomaterials that are based on citric acid. These biomaterials are used for 3D printing medical devices such as stents, drug and protein delivery, and the regeneration several tissues including blood vessels, cartilage, bone, bladder, and skin.” wrote Robert S. Langer, Sc.D. "Dr. Ameer has co-authored numerous publications in high impact journals, book chapters, patents, and conference proceedings and has received several awards for his research." 

This award is Ameer's second from the Society, following his 2021 Clemson Award for Contributions to the Literature.  It was formally awarded during the Society for Biomaterials Annual Meeting and Exposition 2022.  Click here for more information on Citregen and its applications.